Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
JPM24: Merck expects $20B+ in new cancer sales thanks to Daiichi ADC deal, Moderna vaccine
Fierce Pharma
Tue, 01/9/24 - 10:44 am
Merck
JPMHC 2024
Pharma CEOs
Robert Davis
Merck inks $680M Harpoon buyout, spearing challenger to Amgen T-cell engager
Fierce Biotech
Mon, 01/8/24 - 11:36 am
Merck
Harpoon Therapeutics
M&A
T-cell engager
JPMHC 2024
Merck seeks GLP-1 drugs with benefits beyond weight loss - CEO
Reuters
Fri, 01/5/24 - 11:28 am
Merck
Pharma CEOs
Rob Davis
GLP-1 agonist
Merck settles with insurance companies over $1.4B claim tied to 2017 cyberattack: report
Fierce Pharma
Fri, 01/5/24 - 10:08 am
Merck
legal
cybersecurity
cyberattacks
FDA ends busy year with three drug rejections
BioPharma Dive
Tue, 01/2/24 - 10:13 pm
FDA
Amgen
Zealand Pharma
Merck
Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time
BioSpace
Thu, 12/21/23 - 11:36 am
Merck
gefapixant
chronic cough
FDA
FDA accepts Merck’s pneumococcal vaccine BLA for priority review
Pharmaceutical Technology
Wed, 12/20/23 - 09:34 am
Merck
vaccines
FDA
pneumococcal disease
V116
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
Fierce Pharma
Tue, 12/19/23 - 10:26 am
Merck
Astellas
Pfizer
Keytruda
Padcev
bladder cancer
Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark
BioSpace
Thu, 12/14/23 - 10:55 pm
Moderna Therapeutics
Merck
vaccines
Keytruda
melanoma
MRNA
Merck offers up to $610M for one of C4’s protein degraders
Fierce Biotech
Tue, 12/12/23 - 11:07 am
Merck
C4 Therapeutics
protein degradation
Moderna, Merck begin late-stage study for mRNA cancer therapy
Reuters
Mon, 12/11/23 - 10:00 am
Moderna Therapeutics
Merck
MRNA
cancer
clinical trials
Merck suffers bad week as 3 Keytruda combination trials fail
BioPharma Dive
Sun, 12/10/23 - 11:19 pm
Merck
Keytruda
clinical trials
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer
Fierce Pharma
Thu, 12/7/23 - 12:00 pm
Merck
Keytruda
non-small cell lung cancer
Lynparza
AstraZeneca
Merck partners with HiberCell for Phase Ib renal carcinoma trial
Clinical Trials Arena
Wed, 12/6/23 - 10:29 am
Merck
HiberCell
Welireg
HC-7366
renal cell carcinoma
BMS chases Merck/Seagen with first-line bladder cancer filing
Pharmaphorum
Tue, 12/5/23 - 11:53 pm
Bristol Myers Squibb
Opdivo
bladder cancer
urothelial cancer
Merck
Seagen
FDA starts review of Padcev/Keytruda for bladder cancer
Pharmaphorum
Fri, 12/1/23 - 09:35 am
Merck
Astellas
Seagen
Padcev
bladder cancer
FDA
priority review
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
Fierce Biotech
Thu, 11/30/23 - 10:07 am
Merck
GSK
chronic cough
Bellus Health
gefapixant
Camlipixant
Merck turns to Acclinate to increase African American participation in cancer trials
Fierce Biotech
Thu, 11/30/23 - 09:52 am
Merck
clinical trials
clinical trial diversity
Acclinate
cancer
digital health
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Fierce Pharma
Tue, 11/28/23 - 11:52 am
Merck
Pfizer
vaccines
clinical trials
pneumococcal disease
V116
Prevnar 20
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »